Shore Bancshares, Inc. — Q2 2022 Form 10-Q
Business context and period. Unaudited results cover the quarter and six months ended June 30, 2022. Shore Bancshares is a Maryland-based bank holding company operating Shore United Bank, with community banking and mortgage-banking segments. Comparisons are affected by the October 2021 acquisition of Severn Bancorp; the prior-year periods do not include Severn.
Financial performance and condition
- Q2 earnings: Net income was $7.5 million, or $0.38 per diluted share, versus $4.0 million and $0.34 a year earlier. Net interest income was $24.6 million versus $14.1 million; noninterest income was $5.8 million versus $2.9 million; and noninterest expense was $20.1 million versus $10.9 million.
- Six-month earnings: Net income was $13.1 million versus $8.0 million. Diluted EPS declined to $0.66 from $0.68, as the share count increased substantially following the Severn transaction. Net interest income rose to $47.0 million from $27.9 million; noninterest income rose to $11.9 million from $5.5 million.
- Interest margins: Q2 net interest margin was 3.10%, up from 2.91% in Q2 2021 and 2.78% in Q1 2022. First-half margin was 2.94%, compared with 2.96% a year earlier. Management attributed Q2 improvement to higher average loan balances, acquired-loan accretion, and improved yields on earning assets.
- Credit costs and quality: Q2 provision for credit losses was $0.2 million; first-half provision was $0.8 million. The allowance was $15.5 million, or 0.68% of loans (0.89% excluding PPP and acquired loans). Q2 net recoveries were $0.6 million. Nonperforming assets were $3.7 million, up from $3.0 million at year-end; nonaccrual loans were $2.7 million.
- Balance sheet and liquidity: Total assets were $3.44 billion, down slightly from $3.46 billion at December 31, 2021. Loans held for investment were $2.26 billion, up $145.4 million; deposits were $3.01 billion, down $11.9 million. Cash and cash equivalents fell to $403.0 million from $583.6 million. First-half operating cash flow was $43.1 million; investing cash use was $203.2 million and financing cash use was $20.4 million. Management cited loan growth and securities purchases as key uses of cash and reported $15 million in correspondent-bank federal funds lines, in addition to FHLB access.
- Debt and capital: Total borrowings were $53.0 million, including $10.1 million of long-term FHLB advances and $42.9 million of subordinated debt. The Bank’s June 30 capital ratios were 9.45% Tier 1 leverage, 13.39% common equity Tier 1 and Tier 1 risk-based, and 14.05% total risk-based capital. The company reported 8.65%, 12.22%, 12.22%, and 14.70%, respectively.
- Other comprehensive loss: First-half unrealized losses on available-for-sale securities, net of tax, were $6.7 million, moving accumulated other comprehensive income to a $6.7 million loss. Management attributed securities losses to market interest-rate increases, not credit concerns, and stated it did not expect to sell the securities before recovery or maturity.
Material changes and management commentary
- Management attributed much of the increase in revenue and expenses versus 2021 to Severn. Q2 net income excluding merger-related expenses was $7.7 million; merger-related expense was $0.2 million in Q2 and $1.0 million for the first half.
- Legacy loans excluding PPP increased $263.5 million, or 17%, from year-end. Commercial real estate and construction loans together were about 53.7% of total loans. Non-owner-occupied CRE, including construction, land and land development, was 292.2% of risk-based capital; the portfolio had grown 103.5% over three years. Management said it applies heightened monitoring and stress testing, but noted the concentration could require higher capital or loan sales/participations.
- The company provided no specific financial guidance. It cautioned that interim results are not necessarily indicative of full-year results and that forward-looking statements are subject to risks and uncertainties.
- On July 6, 2022, after quarter-end, Shore authorized repurchases of up to $5.0 million of common stock through March 31, 2023. The program may be limited or terminated at any time.
Risks, contingencies, and unusual items
- The company expanded its cannabis-banking program during Q2 to include adult-use licensees in other states. Cannabis activity remains illegal under federal law; the company disclosed potential legal and regulatory exposure, uncertain financial impact, and no accrual for possible actions. Cannabis customers represented approximately $27.0 million of deposits and $42.3 million of loans at June 30.
- Interest-rate changes affect securities values and the company’s market risk. The filing also identifies risks in CRE lending and mortgage loan sale representations, which could require repurchase or indemnification if breached.
- Off-balance-sheet commitments to extend credit were $404.3 million and letters of credit were $9.1 million. Management did not expect current litigation to materially affect financial condition, results, or liquidity. Management reported disclosure controls were effective and no material Q2 change in internal control over financial reporting.
- CECL adoption was scheduled for fiscal years beginning after December 15, 2022; the company was running parallel model simulations and had not determined the standard’s potential impact.
Important facts for investors to verify
- How much of reported earnings growth reflects Severn’s contribution, acquired-loan accretion, and merger-related costs, and how will integration affect expenses?
- Whether loan growth and deposit trends remain sustainable, and how liquidity will respond to continued lending, securities investment, and changing deposit costs.
- Credit performance and reserve adequacy, particularly in commercial real estate and construction, as interest rates and economic conditions change.
- The impact of rising rates on net interest margin, securities fair values, and regulatory capital, including the substantial unrealized loss position in securities.
- Potential legal, regulatory, and financial consequences of the expanded cannabis-banking program, and whether the new repurchase authorization is used.